Clinical Trials

    A Study of Biological Markers for the Nervous and Immune Systems and Free Radical Mediated Processes in Amyotrophic Lateral Sclerosis (ALS)

    Investigator: Stanley Appel

    Study Coordinator: KaDeesia Brown

    Status: Enrolling

    ClinicalTrials.gov Number: NCT99999999

    Phone: 713.441.9120

    Protocol Number: PRO00026718

    Description


    The purpose of this protocol is to develop and maintain a biospecimen bank comprised of blood, urine, CSF collected during diagnostic evaluations, tissue from biopsies and autopsies collected from patients with neurological disease and non-neurologically affected age-matched volunteers.